The first stop for professional medicines advice

Medicines planning

61 results

Applied filters

Repeat supply or administration of medicines under PGD

26 April 2021Patient Group Directions are not an appropriate mechanism for regular repeated supplies or administration of a medicine. Prescribing is preferred.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Biosimilars

Regularly updated material to support the introduction of adalimumab, eculizumab, natalizumab, ranibizumab, tocilizumab and ustekinumab biosimilars.

Planning

We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.

Labelling medicines supplied without a prescription

9 September 2020Advice on the legal labelling requirements for Prescription Only Medicines and Pharmacy Medicines supplied under a patient group direction or legal exemption.

Inclusion of dose ranges in a single Patient Group Direction

9 September 2020The below summarises the considerations required if a single PGD is to include a range of doses.

National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice

4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…

National Homecare Medicines Committee (NHMC) Homecare Digital Strategy

4 August 2020This is the NHMC and NCHA joint digital strategy and roadmap for the next 5 years. It sets out a direction of travel for homecare…

Lists of new product launches

11 February 2020Annual lists of new products and formulations that have launched, and had licence changes approved. Usually published each February.

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.
admin